Actively Recruiting
Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Patients Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2026-05-01
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the safety and effectiveness of abdominal pressure devices to reduce respiratory movement in patients with non-small cell lung cancer. The main goal is to determine if these devices can limit tumor movement during breathing in patients undergoing stereotactic radiotherapy. This observational study is led by Tianjin Medical University Cancer Institute and Hospital and focuses on lung cancer patients suitable for this targeted treatment. Participants will be grouped based on whether they use breathing management with abdominal compression or have no breathing management. The study involves two types of scans: CT/4DCT scans with and without breathing management. The abdominal compression device is applied to suppress respiratory movement to help control tumor motion during treatment. During the study, participants will record how much they use the abdominal pressure devices. Researchers will monitor tumor displacement range within six months after enrollment using imaging scans. This helps assess how well the device controls tumor movement. The study lasts up to six months, focusing on safety, effectiveness, and patient adherence to using the device during radiotherapy.
CONDITIONS
Brief Title
Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of solitary peripheral lung cancer
- Suitable for stereotactic body radiotherapy (SBRT) based on comprehensive clinical evaluation
- Adults aged 18 years or older
You will not qualify if you...
- Central or super central lung cancer
- Patients intolerant or unwilling to undergo respiratory suppression
- Patients intolerant or unwilling to use chest and abdominal compression fixation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 6 months after enrollment
Participants undergo CT/4DCT scans to evaluate tumor displacement with or without breathing management.
1 to 2 visits depending on breathing management group assignment
Duration - Up to 6 months after enrollment
Participants are observed for tumor displacement range after imaging assessments.
Follow-up visits as scheduled
Trial Site Locations
Total: 1 location
1
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Actively Recruiting
Research Team
X
Xuyao Yu Dr
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here